Session » Osteoarthritis – Clinical Aspects - Poster II

Date: Tuesday, November 15, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2343

A Phase 2, Multi-Center, Randomized, Double-Blind, Active-Controlled, Parallel Group Study to Evaluate the Safety and Dose Effectiveness of Intradermal Injections of Purified Apis Mellifera Toxin to Improve Pain and Physical Function in Patients with Osteoarthritis of the Knee

9:00AM-11:00AM: Abstract Number: 2368

Analysis of Pain and Function Components in Omeract-Oarsi Strict Responders from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee

9:00AM-11:00AM: Abstract Number: 2367

Association Between MRI-Detected Osteophytes and Changes in Knee Pain and Structures in Older Adults: A Population Based Cohort Study

9:00AM-11:00AM: Abstract Number: 2361

Association Between Osteoarthritis and Dyslipidemia: A Systematic Literature Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 2356

Comparison of Spa Therapy with or without Physical Rehabilitation for Knee Osteoarthritis: A Randomized Controlled Trial

9:00AM-11:00AM: Abstract Number: 2348

Does Arthritis in Other Joints and Spine Influence the 1-Year Outcome of Total Hip Replacement? a Prospective European Multicenter Cohort Study Measuring the Influence of Musculoskeletal Morbidity

9:00AM-11:00AM: Abstract Number: 2359

Dose-Related Risks of Cardiovascular, Gastrointestinal, and Renal Adverse Events Associated with Meloxicam Among Patients with Osteoarthritis: An Observational Study Using US Claims Data

9:00AM-11:00AM: Abstract Number: 2371

Effect of Etanercept on Several Soluble Biomarkers in a Randomized Controlled Trial of Patients with Erosive Hand Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2372

Effect of Oxytocin on Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2370

Factors Affecting Interval Changes in Perceived Fatigue over Five Years in Patients with Rheumatoid Arthritis Compared with Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2358

High-Fat Diet Is Associated with a Higher Incidence of Radiographic Knee OA and Progression of Knee Joint Space Narrowing: Data from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 2355

Histology of Bone Marrow Lesions in Osteoarthritis: A Systematic Literature Review

9:00AM-11:00AM: Abstract Number: 2344

Inflammation and Glucose Homeostasis Are Associated with Specific Structural Features Among Adults without Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2349

Longitudinal Construct Validity for Four Patient-Reported Outcomes Measurement Information System (PROMIS) Short Forms: Physical Function, Pain Interference, Depression, and Anxiety Among Adults with Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2369

Obesity and Severity of Joint Space Narrowing Are Associated with Viscosupplementation Failure in Patients with Knee Osteoarthritis. Post-Hoc Analysis of a Double-Blind, Controlled, Multicentre, Randomized Trial

9:00AM-11:00AM: Abstract Number: 2352

Obesity-Related Systemic Inflammation and Knee Synovitis

9:00AM-11:00AM: Abstract Number: 2373

Patient Preference for Display of Electronic Patient-Reported Outcomes in Osteoarthritis Clinical Trials: Wording Emphasis, Question Format, and Navigation Button Placement

9:00AM-11:00AM: Abstract Number: 2354

Pharmaceutical Grade Chondroitin Sulfate Improves Knee Osteoarthritis Symptoms More Than Placebo and As Much As Celecoxib: Results of the Chondroitin Vs Celecoxib Vs Placebo Trial (CONCEPT)

9:00AM-11:00AM: Abstract Number: 2362

Progression of Pain and Ultrasound Detected Synovitis in Patients with Erosive Hand Osteoarthritis over One Year

9:00AM-11:00AM: Abstract Number: 2351

Racial Differences in Magnetic Resonance Image-Based Three-Dimensional Bone Shape of the Knee: Data from the Osteoarthritis Initiative (OAI)

9:00AM-11:00AM: Abstract Number: 2350

Radiographic Outcomes from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee

9:00AM-11:00AM: Abstract Number: 2353

Radiographic Variations in Hip Morphology Are Associated with Hip Symptoms: A Cross-Sectional Analysis of a Large Community-Based Cohort

9:00AM-11:00AM: Abstract Number: 2345

Relation of Varus Knee Thrust during Walking to Two-Year Incidence of Frequent Ankle, Hip, and Lower Back Pain

9:00AM-11:00AM: Abstract Number: 2347

Serum Levels of Resistin Are Associated with Synovial Inflammation and Knee Structural Changes in Patients with Symptomatic Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2364

Swimming May Associate with Less Osteoarthritis: Data from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 2363

Synovial Changes Detected By Ultrasound and Its Association with Knee Pain: A Population-Based Case Control Study

9:00AM-11:00AM: Abstract Number: 2360

The Association of Superolateral Hoffa’s Fat Pad Edema and Synovitis with Structural Changes in the Patellofemoral and Tibiofemoral Joints: The Multicenter Osteoarthritis Study

9:00AM-11:00AM: Abstract Number: 2366

The Clinical Utility of the Bulge Sign in Evaluating Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2365

The Cross-Sectional and Longitudinal Associations Between Metabolic Syndrome and Hand Osteoarthritis – Data from the Framingham Study

9:00AM-11:00AM: Abstract Number: 2346

The Improving Motivation for Physical Activity in Arthritis Clinical Trial for Adults with Knee Osteoarthritis and Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2357

Topical Application of Aceclofenac Might NOT Produce a Significant Increase of Blood Pressure in Osteoarthritic Patients – a Continuous Automated Blood Pressure Monitor Study

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].